Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer
To investigate the acute toxicities, late toxicities, and treatment results when the early cervical cancer patients are treated by concurrent chemotherapy with hypofractionated intensity-modulated radiotherapy (2.5 Gy X 16 fractions, once a day) after radical hysterectomy.
Cervix Cancer|Radiotherapy, Adjuvant|Radiotherapy, Intensity-Modulated|Hypofractionated Dose|Chemotherapy, Concurrent
OTHER: POHIM-CCRT
Acute toxicities according to CTCAE v4.0, evaluation of acute toxicities within 3months after radiotherapy according to CTCAE v4.0, 3 months
Late toxicities according to CTCAE v4.0, evaluation of late toxicities every year after 3months after radiotherapy according to CTCAE v4.0, 5-years|Progression free survival rate, progression free survival rate after the time of surgery, 5-years
To investigate the acute toxicities, late toxicities, and treatment results when the early cervical cancer patients are treated by concurrent chemotherapy with hypofractionated intensity-modulated radiotherapy (2.5 Gy X 16 fractions, once a day) after radical hysterectomy.